# 68Ga-citrate PET/MR Imaging for Glioma

> **NCT03335280** · — · TERMINATED · sponsor: **Susan Chang** · enrollment: 2 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** 68Ga-citrate PET/MR

## Key facts

- **NCT ID:** NCT03335280
- **Lead sponsor:** Susan Chang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-26
- **Primary completion:** 2020-04-24
- **Final completion:** 2020-04-24
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Low Accrual
- **Last updated:** 2020-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03335280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03335280, "68Ga-citrate PET/MR Imaging for Glioma". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03335280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*